Shopping Cart
- Remove All
Your shopping cart is currently empty
LUF6000 is an allosteric modulator of the human A3 adenosine receptor (AR).

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 5 mg | $327 | 6-8 weeks | |
| 25 mg | $767 | 6-8 weeks | |
| 50 mg | $997 | 6-8 weeks | |
| 100 mg | $1,750 | 6-8 weeks | |
| 1 mL x 10 mM (in DMSO) | $358 | 6-8 weeks |
| Description | LUF6000 is an allosteric modulator of the human A3 adenosine receptor (AR). |
| In vitro | LUF6000 converted a nucleoside A3 AR antagonist MRS542, but not a non-nucleoside antagonist MRS1220, into an agonist. LUF6000 exerted an Emax-enhancing effect at a concentration of 0.1 microM or higher and was shown to increase the Emax of Cl-IB-MECA and other low-efficacy agonists to a larger extent than that of the high-efficacy agonist NECA. A3 adenosine receptor LUF6000 was found to be an allosteric enhancer of Emax of structurally diverse agonists at the A3 AR, being more effective for low-Emax agonists than for high-Emax agonists. |
| Molecular Weight | 411.33 |
| Formula | C22H20Cl2N4 |
| Cas No. | 890087-21-5 |
| Relative Density. | 1.401 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| Solubility Information | DMSO: 14.29 mg/mL (34.74 mM), Sonication is recommended. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.